Critically, VTN expression correlated with key immunomodulators: positive associations with CXCL12 (a chemokine promoting T-cell recruitment) and negative trends with PD-L1/CTLA4 (immune checkpoint mediators) suggest that VTN may remodel the tumor immune microenvironment. The gene discussed is CTLA4; the disease is neoplasm.